Author

Natalia Echeverria

Asistente Grado 2, Facultad de Ciencias, UdelaR - Cited by 376 - virology - bacteriology

Biography

Natalia Echeverria is a well-known researcher working in Molecular Virology Laboratory, Nuclear Research Center, University of the Republic of Uruguay and has extended valuable service for many years and has been a recipient of many awards and grants.  
Title
Cited by
Year
Hepatitis C virus genetic variability and evolution
N Echeverría, G Moratorio, J Cristina, P MorenoWorld journal of hepatology 7 (6), 831, 2015201
140
2015
miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence
Y Yu, TKH Scheel, JM Luna, H Chung, E Nishiuchi, MA Scull, ...PLoS pathogens 13 (10), e1006694, 2017201
32
2017
Emergence of KPC-producing Klebsiella pneumoniae in Uruguay: infection control and molecular characterization
C Marquez, A Ingold, N Echeverría, A Acevedo, R Vignoli, ...New microbes and new infections 2 (3), 58-63, 2014201
32
2014
Human endogenous retrovirus np9 gene is over expressed in chronic lymphocytic leukemia patients
S Fischer, N Echeverría, G Moratorio, AI Landoni, G Dighiero, J Cristina, ...Leukemia research reports 3 (2), 70-72, 2014201
30
2014
IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients
N Echeverría, D Chiodi, P López, AS Ciceron, J Angulo, M López-Lastra, ...Virology journal 15 (1), 1-10, 2018201
25
2018
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
P Brown, AC Tan, MA El-Esawi, T Liehr, O Blanck, DP Gladue, ...Database 19, 191
20
2019
Evaluation of SYBR Green real time PCR for detecting SARS-CoV-2 from clinical samples
M Pereira-Gómez, Á Fajardo, N Echeverría, F López-Tort, ...Journal of virological methods 289, 114035, 2021202
19
2021
Association of Single-Nucleotide Polymorphisms in IL28B, but Not TNF-α, With Severity of Disease Caused by Andes Virus
J Angulo, K Pino, N Echeverría-Chagas, C Marco, ...Clinical Infectious Diseases 61 (12), e62-e69, 2015201
19
2015
Naturally occurring NS3 resistance-associated variants in hepatitis C virus genotype 1: their relevance for developing countries
N Echeverría, G Betancour, F Gámbaro, N Hernández, P López, D Chiodi, ...Virus Research 223, 140-146, 2016201
15
2016
Pretreatment hepatitis C virus NS5A/NS5B resistance-associated substitutions in genotype 1 Uruguayan infected patients
F Aldunate, N Echeverría, D Chiodi, P López, A Sánchez-Cicerón, ...Disease Markers 2018, 2018201
14
2018
An evolutionary insight into Newcastle disease viruses isolated in Antarctica
M Sonora, P Moreno, N Echeverría, S Fischer, V Comas, A Fajardo, ...Archives of virology 160, 183-100, 2015201
9
2015
In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?
N Echeverría, V Comas, F Aldunate, P Perbolianachis, P Moreno, ...World Journal of Hepatology 13 (10), 1234-128, 2021202
6
2021
Evaluation of SYBR green real time PCR for detecting SARS-CoV-2 from clinical samples
Á Fajardo, M Pereira-Gómez, N Echeverría, F López-Tort, ...bioRxiv, 2020.05. 13.093609, 2020202
4
2020
Molecular evolution of hepatitis C virus: from epidemiology to antiviral therapy (current research in Latin America)
N Echeverría, P Moreno, J CristinaHuman Virology in Latin America: From Biology to Control, -59, 2017201
3
2017
Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report
F Aldunate, N Echeverría, D Chiodi, P López, A Sánchez-Cicerón, ...BMC Infectious Diseases 1 (1), 1-6, 010
2
2021